Phosphorus Changes Affect Dialysis Patient Mortality Risk
Declines in serum phosphorus over time may improve survival.
Kidney Week 2013 Hyperphosphatemia
Higher PTH and Dietary Protein Intake Hikes Hyperphosphatemia Risk
Worsening or resistant hyperphosphatemia may be an under-appreciated consequence of secondary hyperparathyroidism.
Phosphate Binders Offer No Short-Term Mortality Benefit
Calcium-based and non-calcium-based binder use were associated with similar death risks.
Limiting Phosphorus Additives in Foods Lowers Serum Phosphorus
Levels declined significantly from 7.2 to 5.0 mg/dL, data show.
Vascular Calcification Linked to Lower Phosphate Clearance
Vascular calcification contributes to increased cardiovascular risk in dialysis patients.
Oxidative Stress May Be Why High Phosphorus Ups Mortality
New findings are consistent with those from previous animal studies.
Novel Iron-Based Binder Has Long-Term Efficacy
PA21 comparable in safety and efficacy to sevelamer carbonate out to 52 weeks, study finds.
Fasting Phosphorus Levels Are a Stronger Mortality Predictor
Serum levels vary throughout the day, and higher phosphorus intake exaggerates the early afternoon rise in serum phosphorus.
Race May Affect Phosphorus-Mortality Link in CKD Patients
New findings raise questions “on the generalizability of previous research studies to the clinic setting,” researchers conclude.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...